Dentistry Today
AUGUST 3, 2023
The company’s principal products are dental laser systems that cater to a broad range of dental procedures, including cosmetic and complex surgical applications. As of December 31, 2022, the company has sold over 45,500 laser systems in more than 80 countries worldwide.
Dentistry Today
JANUARY 9, 2024
BIOLASE’s principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. From 1998 through December 31, 2022, BIOLASE has sold over 45,500 laser systems in over 80 countries worldwide.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Dentistry Today
MAY 5, 2023
BIOLASE’s principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. From 1998 through December 31, 2022 , the company has sold over 45,500 laser systems in over 80 countries around the world.
Dentistry Today
DECEMBER 13, 2023
The Waterlase iPlus laser is a versatile tool that can be used for a variety of dental procedures, including tooth extractions, periodontal surgery, and cavity fillings. The laser is also FDA-approved for use in treating periodontal disease.
Dentistry Today
JUNE 15, 2023
BIOLASE’s principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. From 1998 through December 31, 2022 , BIOLASE has sold over 45,500 laser systems in over 80 countries around the world.
Dentistry Today
JANUARY 4, 2024
The principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. From 1998 through December 31, 2022, BIOLASE has sold over 45,500 laser systems in over 80 countries worldwide.
Dentistry Today
JANUARY 29, 2024
The company believes it is well-positioned with its industry-leading dental lasers and broad intellectual property (“IP”) portfolio to capitalize on the significant market opportunity for dental laser adoption and, with the year-end cash and cash equivalents balance of $6.6
Expert insights. Personalized for you.
244 
Let's personalize your content